Eulav Asset Management Pet Iq, Inc. Transaction History

Eulav Asset Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$24.99 - $38.45 $639,744 - $984,320	-25,600 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$29.04 - $37.49 $174,240 - $224,940	6,000 Added 30.61%	25,600 $843,000
Q1 2020 Apr 27, 2020	SELL	$16.59 - $34.94 $230,601 - $485,665	-13,900 Reduced 41.49%	19,600 $455,000
Q4 2019 Feb 13, 2020	SELL	$22.24 - $27.56 $222,399 - $275,600	-10,000 Reduced 22.99%	33,500 $839,000
Q3 2019 Nov 12, 2019	BUY	$25.56 - $36.1 $299,052 - $422,370	11,700 Added 36.79%	43,500 $1.19 Million
Q3 2018 Oct 26, 2018	BUY	$25.67 - $42.36 $816,306 - $1.35 Million	31,800 New	31,800 $1.25 Million

188

28.6M

78.8K

111K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $902M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.